Kiora Pharmaceuticals, Inc.
KPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,780 | $2,529 | $22,606 | $131,061 |
| - Cash | $3,792 | $2,455 | $5,965 | $7,855 |
| + Debt | $57 | $107 | $106 | $209 |
| Enterprise Value | $9,045 | $181 | $16,747 | $123,416 |
| Revenue | $16,000 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $16,000 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | $5,700 | -$12,361 | -$13,646 | -$13,911 |
| % Margin | 35.6% | – | – | – |
| Net Income | $3,595 | -$12,514 | -$13,584 | -$13,771 |
| % Margin | 22.5% | – | – | – |
| EPS Diluted | 0.87 | -24.25 | -18.55 | -68 |
| % Growth | 103.6% | -30.7% | 72.7% | – |
| Operating Cash Flow | $8,559 | -$9,557 | -$10,428 | -$10,675 |
| Capital Expenditures | -$6 | $0 | $0 | -$64 |
| Free Cash Flow | $8,553 | -$9,557 | -$10,428 | -$10,739 |